Zobrazeno 1 - 10
of 275
pro vyhledávání: '"Chadban SJ"'
Autor:
Sumida, K, Nadkarni, GN, Grams, ME, Sang, Y, Ballew, SH, Coresh, J, Matsushita, K, Surapaneni, A, Brunskill, N, Chadban, SJ, Chang, AR, Cirillo, M, Daratha, KB, Gansevoort, RT, Garg, AX, Iacoviello, L, Kayama, T, Konta, T, Kovesdy, CP, Lash, J, Lee, BJ, Major, R, Metzger, M, Miura, K, Naimark, DMJ, Nelson, RG, Sawhney, S, Stempniewicz, N, Tang, M, Townsend, RR, Traynor, JP, Valdivielso, JM, Wetzels, J, Polkinghorne, KR, Heerspink, HJL, for the CKD Prognosis Consortium.
Background: Although measuring albuminuria is the preferred method for defining and staging chronic kidney disease (CKD), total urine protein or dipstick protein is often measured instead. Objective: To develop equations for converting urine protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::0d44e8652399acf9ae26927730123c0e
http://hdl.handle.net/11588/802435
http://hdl.handle.net/11588/802435
Autor:
Chadban, SJ, Atkins, RC
Publikováno v:
In The Lancet 2005 365(9473):1797-1806
Publikováno v:
Bulletin of the World Health Organization. Mar2008, Vol. 86 Issue 3, p229-237. 9p.
Autor:
Turin TC, Matsushita K, Coresh J, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Irie F, Ix JH, Kovesdy CP, Ohkubo T, Shankar A, Wen CP, De Jong PE, Iseki K, StengelB and Gansevoort RT, Chronic Kidney Disease Prognosis Consortium
Introduction and Aims: Change in estimated GFR (eGFR) is frequently used to track CKD progression in clinical practice, trials and cohort studies but its association with mortality has not been studied extensively. Methods: Change in eGFR was estimat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::ee78f0bef5331f174632f021a8bd5214
http://hdl.handle.net/11588/733136
http://hdl.handle.net/11588/733136
Autor:
Chowdhury Turin T, Matsushita K, Coresh J, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Irie F, Ix JH, Kovesdy CP, Ohkubo T, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT.
Background: Change in estimated GFR (eGFR) is frequently used to track CKD progression in clinical practice, trials and cohort studies but its association with mortality has not been studied extensively. Methods: Change in eGFR was estimated as % cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3730::4ee83b8ff8224b3efdd6d13c1a714984
http://hdl.handle.net/11588/733131
http://hdl.handle.net/11588/733131
Autor:
Chronic Kidney Disease Prognosis Consortium, Matsushita, K, van der Velde, M, Astor, Bc, Woodward, M, Levey, As, de Jong PE, Coresh, J, Investigators/Collaborators: Levey AS, Gansevoort R. T., El Nahas, M, Eckardt, Ku, Kasiske, Bl, Tonelli, M, Hemmelgarn, B, Wang, Y, Atkins, Rc, Polkinghorne, Kr, Chadban, Sj, Shankar, A, Klein, R, Klein, Be, Wang, H, Wang, F, Zhang, L, Liu, L, Shlipak, M, Sarnak, Mj, Katz, R, Fried, Lp, Jafar, T, Islam, M, Hatcher, J, Poulter, N, Chaturvedi, N, Rothenbacher, D, Brenner, H, Raum, E, Koenig, W, Fox, Cs, Hwang, Sj, Meigs, Jb, Cirillo, Massimo, Hallan, S, Lydersen, S, Holmen, J, Roderick, P, Nitsch, D, Fletcher, A, Bulpitt, C, Ohkubo, T, Metoki, H, Nakayama, M, Kikuya, M, Imai, Y, Gansevoort, Rt, Jassal, Sk, Barrett Connor, E, Bergstrom, J, Warnock, Dg, Muntner, P, Judd, S, Mcclellan, Wm, Cushman, M, Howard, G, Mcclure, La, Jee, Sh, Kimm, H, Yun, Je, Wen, Cp, Wen, Sf, Tsao, Ck, Tsai, Mk, Arnlöv, J, Auguste, P, Veldhuis, K, Camarata, L, Thomas, B, Manley, T.
Publikováno v:
LANCET, 375(9731), 2073-2081. ELSEVIER SCIENCE INC
BACKGROUND: Substantial controversy surrounds the use of estimated glomerular filtration rate (eGFR) and albuminuria to define chronic kidney disease and assign its stages. We undertook a meta-analysis to assess the independent and combined associati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c7f4bd261f6edef91d5cf7ee45bff8
http://hdl.handle.net/11386/3080939
http://hdl.handle.net/11386/3080939
Autor:
Turin, Tc, Matsushita, K, Coresh, J, Arima, H, Chadban, Sj, Cirillo, Massimo, Djurdjev, O, Green, Ja, Irie, F, Ix, Jh, Kovesdy, Cp, Ohkubo, T, Shankar, A, Wen, Cp, De Jong PE, Iseki, K, Stengelb, Gansevoort, Rt, Chronic Kidney Disease Prognosis Consortium
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3666::a69855da4bc004f1c11a736aa74d0967
http://hdl.handle.net/11386/4369253
http://hdl.handle.net/11386/4369253
BACKGROUND: Optimal treatment of atrial fibrillation (AF) in the haemodialysis population is uncertain due to the exclusion of this group from randomized trials. The risk-benefit profile for anticoagulation and anti-platelet therapy in haemodialysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::671e0e2f315a4f0c9a51f29d7ffc8e2a
https://hdl.handle.net/2123/14289
https://hdl.handle.net/2123/14289
Background Accurate quantification of albuminuria is important in the diagnosis and management of chronic kidney disease. The reference test, a timed urinary albumin excretion, is cumbersome and prone to collection errors. Spot urine albumin-creatini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::570e77aec0f784afe1cb4a3f17a22bbe
https://hdl.handle.net/10453/116989
https://hdl.handle.net/10453/116989
Autor:
Chowdhury Turin, T, Matsushita, K, Coresh, J, Arima, H, Chadban, Sj, Cirillo, Massimo, Djurdjev, O, Green, Ja, Irie, F, Ix, Jh, Kovesdy, Cp, Ohkubo, T, Wen, Cp, de Jong PE, Iseki, K, Stengel, B, Gansevoort, R. T.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3666::be9c79b66b2741ede99a27ad4f34d45b
http://hdl.handle.net/11386/4308453
http://hdl.handle.net/11386/4308453